Lab Research lands 5 new “top 35” pharma clients
Preclinical CRO Lab Research says new contracts are a sign of continuing recovery in market as well as firm’s ability to attract broader clientele base.
Preclinical CRO Lab Research says new contracts are a sign of continuing recovery in market as well as firm’s ability to attract broader clientele base.
Pantec Biosolutions AG has secured a CHF20m ($19m) investment to further development of its needle-free in vitro fertilisation (IVF) therapy.
Reaxa has received a UK Technology Strategy Board (TSB) award to further development of cleaner catalysts for pharmaceutical manufacturing.